A perspective on the ESVEM trial and current knowledge: Sotalol should not be the first-line agent in the management of ventricular arrhythmias

✍ Scribed by Hasan Garan

• Book ID: 114081241
• Publisher: Elsevier Science
• Year: 1996
• Tongue: English
• Weight: 221 KB
• Volume: 38
• Category: Article
• ISSN: 1532-8643
• DOI: 10.1016/s0033-0620(96)80009-0